BIOMAT Database Logo BIOMAT Database Logo

Controlled release of biologically active drugs. 1976

S Yolles, and T Leaffe, and L Ward, and F Boettner

UI MeSH Term Description Entries
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D004343 Drug Implants Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug. Drug Implant,Drug Pellet,Pellets, Drug,Drug Pellets,Implant, Drug,Implants, Drug,Pellet, Drug
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical

Related Publications

S Yolles, and T Leaffe, and L Ward, and F Boettner
Theory of controlled release of biologically active substances.
December 1973, Archives of environmental contamination and toxicology,
S Yolles, and T Leaffe, and L Ward, and F Boettner
Controlled release of biologically active silver from nanosilver surfaces.
November 2010, ACS nano,
S Yolles, and T Leaffe, and L Ward, and F Boettner
Controlled release of biologically active compounds from bioerodible polymers.
January 1980, Biomaterials,
S Yolles, and T Leaffe, and L Ward, and F Boettner
Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs.
May 2010, Glycoconjugate journal,
S Yolles, and T Leaffe, and L Ward, and F Boettner
Can erythrocytes release biologically active NO?
September 2016, Cell communication and signaling : CCS,
S Yolles, and T Leaffe, and L Ward, and F Boettner
[Biologically active procyanidin content of Crateagus drugs].
March 1984, Acta pharmaceutica Hungarica,
S Yolles, and T Leaffe, and L Ward, and F Boettner
Mitogen-stimulated lymphocytes release biologically active corticotropin.
March 1993, Endocrinology,
S Yolles, and T Leaffe, and L Ward, and F Boettner
RELEASE OF BIOLOGICALLY ACTIVE SUBSTANCES FROM "MAST CELLS".
January 1963, Rendiconti - Istituto superiore di sanita,
S Yolles, and T Leaffe, and L Ward, and F Boettner
A rare example of a porous Ca-MOF for the controlled release of biologically active NO.
September 2013, Chemical communications (Cambridge, England),
S Yolles, and T Leaffe, and L Ward, and F Boettner
[Controlled preparation of biologically active or inactive monoiodoinsulin].
July 1972, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
Copied contents to your clipboard!